HighTower Advisors’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,971
Closed -$315K 3765
2025
Q1
$315K Buy
20,971
+7,618
+57% +$127K ﹤0.01% 2822
2024
Q4
$220K Sell
13,353
-2,530
-16% -$49.9K ﹤0.01% 3125
2024
Q3
$387K Buy
15,883
+1,615
+11% +$41.9K ﹤0.01% 2614
2024
Q2
$361K Buy
14,268
+292
+2% +$7.57K ﹤0.01% 2571
2024
Q1
$356K Buy
13,976
+3,534
+34% +$85.5K ﹤0.01% 2549
2023
Q4
$239K Buy
+10,442
New +$216K ﹤0.01% 2887
2021
Q1
Sell
-9,462
Closed -$425K 3047
2020
Q4
$425K Buy
9,462
+617
+7% +$23.4K ﹤0.01% 1708
2020
Q3
$314K Buy
8,845
+991
+13% +$35.8K ﹤0.01% 1810
2020
Q2
$298K Buy
7,854
+1,035
+15% +$34.1K ﹤0.01% 1741
2020
Q1
$200K Buy
+6,819
New +$276K ﹤0.01% 1790
2019
Q4
Sell
-4,204
Closed -$230K 2327
2019
Q3
$230K Buy
+4,204
New +$216K ﹤0.01% 1972

Other funds holding ANIK